Tranexamic Acid for Pigmentation: The Newer Brightener, Explained

Does tranexamic acid actually fade melasma and dark spots?

Short answer: For melasma, yes — both the cream and the pill have real trial evidence behind them, and they work through a different pathway than most brighteners. For dark spots left by acne or injury, the evidence is thinner. The pill is prescription-only and carries a rare but real clotting risk, so it's not something to self-dose.

How it works — and why it's different from other brighteners

Hydroquinone, kojic acid, and arbutin all directly block tyrosinase, the enzyme your pigment cells use to make melanin. Tranexamic acid doesn't — it was developed to stop bleeding, by blocking an enzyme called plasmin, and dermatologists later noticed it also quiets a UV-triggered chain reaction behind melasma: UV activates plasmin in skin cells, which switches on tyrosinase and releases inflammatory messengers that push pigment production further. TXA blocks that chain near the top, before tyrosinase gets involved, with some general anti-inflammatory effect layered on top [1][8]. See the tranexamic acid ingredient profile for how it shows up in formulas.

Topical TXA: solid, but not a clear win over a good vehicle

The topical evidence is genuinely mixed. In a 2012 split-face trial, 21 women with melasma applied 5% TXA to one side of their face and a matching blank cream to the other, both under sunscreen, for 12 weeks. Both sides lightened, but the TXA side wasn't significantly better than the vehicle, and it caused more redness [2].

Against an actual comparator, TXA does better: a 2019 trial randomized 100 patients to 5% topical TXA or 3% hydroquinone, both under SPF 30, for 12 weeks. Melasma scores dropped about 27% with TXA versus 26.7% with hydroquinone — essentially a tie — but hydroquinone caused significantly more irritation, and TXA patients reported higher satisfaction [3]. Topical TXA reads as a gentler alternative to hydroquinone, even without a clear edge over a good base cream alone.

Oral TXA: stronger results, real screening required

Oral TXA has more consistently positive evidence, and it's also where the safety conversation matters most.

In a 2025 trial, 50 patients took either 250 mg oral TXA twice daily or applied 5% topical TXA cream, both alongside SPF 60 reapplied every three hours, for 12 weeks. Melasma severity dropped about 59% on the oral arm and 51% on the topical arm — both real improvements, with no significant difference between the two [4]. Side effects were mild: 16% of the oral group had lighter or irregular periods, and one topical patient dropped out from irritation [4].

The bigger question is clotting, since TXA is fundamentally an anti-clot-breakdown drug. A Danish cohort of nearly 2 million women taking oral TXA for any reason found roughly 4 times the normal rate of venous blood clots — real, but rare in absolute terms: about 1 extra clot per 78,500 women treated for five days, with no increase in arterial clots [6]. For melasma specifically, at typical doses, the picture looks better: a 2025 study matched 682 melasma patients on TXA against 682 similar patients not on it, and found identical clot rates (1.6%) in both groups over 120 days, with zero arterial clotting events in the treated group [7].

That's why oral TXA needs a prescription. It's off-limits if you're on estrogen-containing birth control, have any personal history of blood clots, or have another clotting risk factor your doctor flags [9]. Pregnancy, breastfeeding, and smoking are also reasons to skip it [8]. None of that makes it a bad option — it just means a doctor rules you in first.

Where it fits in a routine

TXA is an add-on, not a foundation. Melasma gets worse with UV and visible light, so daily broad-spectrum sunscreen still comes first — dermatologists specifically point to mineral filters like zinc oxide and titanium dioxide for melasma-prone skin [10]. TXA usually enters after sunscreen and a first-line brightener haven't fully worked, often as a twice-daily pill [10]. Run a product's ingredient list through our scanner to confirm what's actually in the tube.

FAQ

Can I take oral tranexamic acid if I'm on birth control pills?

Not combined hormonal (estrogen-containing) contraception — that pairing is specifically flagged on the drug's label, since both raise clotting risk [9]. Progestin-only methods are a conversation for your prescriber.

Does tranexamic acid work on dark spots from acne, not just melasma?

The evidence is thinner. A review of 196 patients across nine studies found topical TXA (2–3%) helped mild-to-moderate post-inflammatory marks, sometimes within two weeks, but oral TXA for this use gave inconsistent results with more side effects — topical is the better-supported choice here [5].

Is the topical version basically as good as the pill?

For melasma, they land in the same range — about 51% versus 59% reduction over 12 weeks, a gap that wasn't statistically significant [4]. Topical also skips the clotting conversation, which is why many dermatologists start there.

How long before I'd see a difference?

The trials above measured meaningful melasma improvement at 12 weeks, not days [3][4]. For mild post-inflammatory marks treated topically, some studies reported early change within two weeks, though full results took longer [5].